Results 321 to 330 of about 162,227 (374)

NRF2 signalling in cytoprotection and metabolism

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 1, Page 101-114, January 2026.
The KEAP1‐NRF2 system plays a central role in cytoprotection in defence mechanisms against oxidative stress. The KEAP1‐NRF2 system has been regarded as a sulfur‐utilizing cytoprotective mechanism, because KEAP1 serves as a biosensor for electrophiles by using its reactive thiols and NRF2 is a transcriptional factor regulating genes involved in sulfur ...
Shohei Murakami   +4 more
wiley   +1 more source

Biallelic TMEM126B Variants as a Novel Cause of Kidney Failure—Implications for Mitochondrial Genetic Testing in Nephrology

open access: yesClinical Genetics, Volume 109, Issue 1, Page 206-208, January 2026.
An adult with kidney failure had compound‐heterozygous TMEM126B variants causing mitochondrial complex I deficiency. This expands TMEM126B to mitochondrial nephropathy and supports including mitochondrial genes in renal genetic testing.
Zachary T. Sentell   +7 more
wiley   +1 more source

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden   +3 more
wiley   +1 more source

Altered carnitine-acylcarnitine profiles in levothyroxine-treated congenital hypothyroid patients with fatigue: An LC-MS/MS-based study from Bangladesh. [PDF]

open access: yesPLoS One
Begum MN   +20 more
europepmc   +1 more source

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health

open access: yesJournal of Internal Medicine, Volume 299, Issue 1, Page 20-43, January 2026.
Abstract Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline. Although amyloid‐β and tau pathologies remain central to our understanding of AD, growing evidence suggests that disrupted lipid metabolism and impaired bioenergetics are closely linked to these hallmark features. Genetic, lipidomic
Silvia Maioli   +12 more
wiley   +1 more source

Serum acylcarnitines profile at ICU discharge to predict mid-term muscle outcomes: an exploratory study. [PDF]

open access: yesFront Med (Lausanne)
Rousseau AF   +6 more
europepmc   +1 more source

Acute L-Carnitine Supplementation Does Not Improve CrossFit<sup>®</sup> Performance: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. [PDF]

open access: yesNutrients
Devrim-Lanpir A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy